Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting CDK6 in cancer: State of the art and new insights
Solomon Tadesse, Mingfeng Yu, Malika Kumarasiri, et al.
Cell Cycle (2015) Vol. 14, Iss. 20, pp. 3220-3230
Open Access | Times Cited: 129

Showing 26-50 of 129 citing articles:

Aberrant MicroRNA Expression and Its Implications for Uveal Melanoma Metastasis
Kyra N. Smit, Jiang Chang, Kasper Derks, et al.
Cancers (2019) Vol. 11, Iss. 6, pp. 815-815
Open Access | Times Cited: 39
Identification of Novel CDK 4/6 Inhibitors by High-throughput Virtual Screening
Abhijit Debnath, Rupa Mazumder
Letters in Drug Design & Discovery (2024) Vol. 21, Iss. 15, pp. 3229-3246
Closed Access | Times Cited: 4
Multicomponent reactions for the synthesis of tetrazole derivatives: Discovery and validation of a novel anticancer agent active against ER positive cancers
Deepak J. Prabhu, Franklin John, Mathew Steephan, et al.
Results in Chemistry (2024) Vol. 7, pp. 101470-101470
Open Access | Times Cited: 4
Current Novel Targeted Therapeutic Strategies in Multiple Myeloma
Cindy Hsin-Ti Lin, Muhammad Junaid Tariq, Fauzia Ullah, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6192-6192
Open Access | Times Cited: 4
Targeting cyclin-dependent kinase 11: a computational approach for natural anti-cancer compound discovery
Suruchi Bhambri, Prakash C. Jha
Molecular Diversity (2025)
Closed Access
CDK6-Dependent, CDK4-Independent Synovial Hyperplasia in Arthritic Mice and Tumor Necrosis Factor-α-Induced Proliferation of Synovial Fibroblasts
Rie Komatsu, Ryoji Fujii, Toru Ogasawara, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1151-1151
Open Access
Binding Mechanism of Inhibitors to CDK6 Deciphered by Multiple Independent Molecular Dynamics Simulations and Free Energy Predictions
Lifei Wang, Yan Wang, Lulu Zhang, et al.
Molecules (2025) Vol. 30, Iss. 5, pp. 979-979
Open Access
B-AP15 inhibited colon cancer cell proliferation by decreasing CDK6, Cyclin A, Cyclin E, c-Myc, and VEGF gene expression
Thanet Sophonnithiprasert, Sasiwan Konjanthet, Nattanicha Narinnork, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Cdk5 in Oncology: Recent Advances and Future Prospects
Jimma Likisa Lenjisa, Solomon Tadesse, Nishat Zareen Khair, et al.
Future Medicinal Chemistry (2017) Vol. 9, Iss. 16, pp. 1939-1962
Open Access | Times Cited: 37
Advances in Molecular Profiling and Categorisation of Pancreatic Adenocarcinoma and the Implications for Therapy
Rille Pihlak, Jamie Weaver, Juan W. Valle, et al.
Cancers (2018) Vol. 10, Iss. 1, pp. 17-17
Open Access | Times Cited: 37
Naringenin as a potential inhibitor of human cyclin-dependent kinase 6: Molecular and structural insights into anti-cancer therapeutics
Mohd Yousuf, Anas Shamsi, Shama Khan, et al.
International Journal of Biological Macromolecules (2022) Vol. 213, pp. 944-954
Open Access | Times Cited: 18
Cyclin-dependent kinase 4/6 inhibitor-associated thromboembolism: a critical evaluation of the current evidence
Nathan Watson, Joseph J. Shatzel, Hanny Al‐Samkari
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 4, pp. 758-770
Open Access | Times Cited: 9
Deciphering the binding behavior of flavonoids to the cyclin dependent kinase 6/cyclin D complex
Jingxiao Zhang, Lilei Zhang, Yangcheng Xu, et al.
PLoS ONE (2018) Vol. 13, Iss. 5, pp. e0196651-e0196651
Open Access | Times Cited: 24
miR-4429Inhibits Tumor Progression and Epithelial-Mesenchymal Transition Via TargetingCDK6in Clear Cell Renal Cell Carcinoma
Hong Pan, Yejing Hong, Biying Yu, et al.
Cancer Biotherapy and Radiopharmaceuticals (2019) Vol. 34, Iss. 5, pp. 334-341
Open Access | Times Cited: 24
Inducible deletion of CDK4 and CDK6 – deciphering CDK4/6 inhibitor effects in the hematopoietic system
Barbara Maurer, Tania Brandstoetter, Sebastian Kollmann, et al.
Haematologica (2020) Vol. 106, Iss. 10, pp. 2624-2632
Open Access | Times Cited: 21
LC/MS analysis of Viscum cruciatum Sieber ex Boiss. extract with anti-proliferative activity against MCF-7 cell line via G0/G1 cell cycle arrest: An in-silico and in-vitro study
Fatma Abo-Elghiet, Mona H. Ibrahim, Mahmoud A. El Hassab, et al.
Journal of Ethnopharmacology (2022) Vol. 295, pp. 115439-115439
Closed Access | Times Cited: 13
Targeting Cyclin-Dependent Kinases in Ovarian Cancer
Qi Zhou
Cancer Investigation (2017) Vol. 35, Iss. 6, pp. 367-376
Closed Access | Times Cited: 23
Knockdown of long non-coding RNA HOST2 inhibits the�proliferation of triple negative breast cancer via regulation of the let-7b/CDK6 axis
Zhang Yuedong, Hongwei Zhang, Huiqing Kang, et al.
International Journal of Molecular Medicine (2018)
Open Access | Times Cited: 23
EphA2 promotes tumorigenicity of cervical cancer by up‐regulating CDK6
Changhao Huang, Zihua Chen, Yihong He, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 6, pp. 2967-2975
Open Access | Times Cited: 17
In silico development and experimental validation of a novel 7-gene signature based on PI3K pathway-related genes in bladder cancer
Linhui Wang, Yutao Wang, Jianbin Bi
Functional & Integrative Genomics (2022) Vol. 22, Iss. 5, pp. 797-811
Open Access | Times Cited: 11
Multitarget Ensemble Docking of Potent Anticancer and Antioxidant Active Compounds from the Acacia auriculiformis and Acacia crassicarpa
Yanico Hadi Prayogo, Setyanto Tri Wahyudi, Irmanida Batubara, et al.
Research Journal of Pharmacy and Technology (2024), pp. 707-716
Closed Access | Times Cited: 2
CircPRMT5 promotes progression of osteosarcoma by recruiting CNBP to regulate the translation and stability of CDK6 mRNA
Yunlu Liu, Hongyan Jiang, Keli Hu, et al.
PLoS ONE (2024) Vol. 19, Iss. 4, pp. e0298947-e0298947
Open Access | Times Cited: 2
MR-Based Radiomics Predicts CDK6 Expression and Prognostic Value in High-grade Glioma
Chen Sun, Chenggang Jiang, X. L. Wang, et al.
Academic Radiology (2024) Vol. 31, Iss. 12, pp. 5141-5153
Open Access | Times Cited: 2
Umbelliprenin improved anti-proliferative effects of ionizing radiation on adult T-cell leukemia/lymphoma cells via interaction with CDK6; an in vitro and in silico study
Keyhan Ebrahimi, Ramin Khameneh Bagheri, Hamid Gholamhosseinian, et al.
International Journal of Immunopathology and Pharmacology (2024) Vol. 38
Open Access | Times Cited: 2
Synthesis, cytotoxic evaluation, and molecular docking studies of the semi-synthetic “triterpenoid-steroid” hybrids
И. А. Толмачева, Alexey V. Nazarov, Daria V. Eroshenko, et al.
Steroids (2018) Vol. 140, pp. 131-143
Closed Access | Times Cited: 20

Scroll to top